BioSpace News Archive

A recent study, partially supported by the INC and published in the journal Nutrients1, observed a significant increase in erectile function after the consumption of 60 g/day of nuts.

With a continuous commitment to the promotion and execution of socially responsible company management, Rite Aid has released its inaugural corporate social responsibility report.

MedAustron, RaySearch’s first customer for carbon ion therapy treatment planning in RayStation back in 2012, has now decided to replace existing systems and only use RaySearch software exclusively.

Developing technology to more accurately predict the progression of a patient’s rare disease can help physicians choose the most effective and least invasive treatment.

Pfizer Inc. opens a call for interested U.S. startup companies to submit non-confidential proposals for a Pfizer-sponsored LabCentral “Golden Ticket.”

Encompass Health Corporation (NYSE: EHC) (“Encompass Health” or the “Company”) today settled a seven-year False Claims Act (“FCA”) investigation by the Department of Justice (“DOJ”), together with related qui tam or “whistleblower” lawsuits, for a settlement payment of $48 million.

In recognition of the importance of HIV testing and early diagnosis of HIV, AscellaHealth, a specialty-focused pharmaceutical management company serving commercial, Medicare and Medicaid segments, joins the Centers for Disease Control and Prevention in supporting June 27, 2019, as National HIV Testing Day.

Howard University Hospital announced the opening of a new Women, Infants and Children Family Center at the Joint Base Anacostia –Bolling, located at 53 MacDill Boulevard SW, Washington, D.C. The new center will provide low income, military families with infants and children access to healthy foods, nutritional and educational counseling, breastfeeding support, health care and immunization resources, and community-based social services.

Home infusion provider opens a new facility serving patients in the greater Atlanta area

Oncimmune Holdings plc (AIM: ONC.L), – a leading global immunodiagnostics group, today announces it has entered into an exclusive partnership agreement which it believes will unlock the full potential of EarlyCDT® Lung in the United States, bringing this lung cancer test to more patients as a result